Clinical trial / 2002
Oral cobalamin at 1,000 mcg daily effectively normalized elevated methylmalonic acid levels in cobalamin-deficient older adults.
Researchers tested sequential 6-week daily treatments of 25 mcg, 100 mcg, and 1,000 mcg oral cobalamin in 23 older adults with cobalamin deficiency. Daily treatment with 25 mcg and 100 mcg lowered but did not normalize MMA levels in most participants, whereas 1,000 mcg/day was the most effective in lowering MMA to normal limits. Serum tHcy normalized in 6 of 11 participants with elevated baseline tHcy using oral cobalamin alone, and in 1 participant in combination with a multivitamin.
- Study type
- Sequential nonrandomized intervention study
- Who was studied
- 23 older adults aged 65 and older with low cobalamin and elevated methylmalonic acid
- What was measured
- Serum methylmalonic acid (MMA) and total homocysteine (tHcy) concentrations
THE PAPER
Response of elevated methylmalonic acid to three dose levels of oral cobalamin in older adults.
Rajan S, Wallace JI, Brodkin KI, Beresford SA, Allen RH, Stabler SP. J Am Geriatr Soc, 2002.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.